Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the …

A study has shown that Avacta’s AffiDX antigen lateral flow test can detect the Delta variant of COVID-19. The test …
Biotherapeutic and research reagent developer Avacta has announced it will collaborate with New York’s Memorial Sloan Kettering Cancer Center (MSK, …

Cotrel joins Avacta from Abcam, where he held the role of commercial operations director.He will lead the Group’s commercial strategy …

